跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
25-Hydroxycholesterol
首页
药物
25-Hydroxycholesterol
Experimental
Small Molecule
25-Hydroxycholesterol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
27
H
46
O
2
CAS 编号
2140-46-7
UNII ID
767JTD2N31
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Hydroxycholesterol immunoassay
US 8969525 B2
申请人: MULLENIX MICHAEL C
优先权: 2010
US
6 件公开
Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
US 9034859 B2
申请人: REN SHUNLIN
优先权: 2012
US
3 件公开
Compositions for the treatment of cataracts
US 10398709 B2
申请人: CATACORE INC
优先权: 2015
CN
US
2 件公开
OPHTHALMIC FORMULATION FOR PREVENTING AND/OR TREATING CATARACTS BY EYE DROP ADMINISTRATION
US 20250000791 A1
申请人: CHENGDU RUIMU BIOPHARMACEUTICALS CO LTD
优先权: 2021
EP
US
2 件公开
ORGANIC COMPOUNDS
US 2011243923 A1
申请人: NOVARTIS AG
优先权: 2009
US
2 件公开
BROAD ANTIVIRAL THERAPY WITH MEMBRANE MODIFYING OXYSTEROLS
US 2015133420 A1
申请人: UNIV CALIFORNIA
优先权: 2013
US
2 件公开
Preparation containing 25-hydroxycholesterol and preparation method thereof and anti-virus application
CN 105362278 A
申请人: SUZHOU INST OF SYSTEMS MEDICINE
优先权: 2014
CN
Drug for inhibiting intra-cellular replication in porcine reproductive and respiratory syndrome virus (PRRSV)
CN 107308168 A
申请人: UNIV CHINA AGRICULTURAL
优先权: 2017
CN
Application of 25-hydroxycholesterol in preparation of aquatic organism disease prevention and treatment preparation
CN 112471013 A
申请人: UNIV SHANDONG
优先权: 2020
CN
Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes, and prediabetes
US 12642805 B2
申请人: MEDICIS PHARMACEUTICAL CORP
优先权: 2021
US
第 1 / 2 页
上一页
下一页
药物
反馈